Recent research focusing on Semaglutide at a dosage of 20mg is shedding new light on its potential effects. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood sugar, potentially offering greater outcomes for individuals with type 2 diabetes. Further study is underway to fully understand the long-term impac